Organon (OGN) Net Income towards Common Stockholders (2020 - 2026)
Organon (OGN) posted Net Income towards Common Stockholders of $164 million for Q3 2026, up 2.5% from $160 million a year earlier and up 51.9% from the prior quarter.
Powered by 
Analysis
Organon (OGN) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Income towards Common Stockholders at Organon was $213 million, down 57.5% year-over-year; for FY2025, it was $187 million, down 78.4% from FY2024.
- Annual Net Income towards Common Stockholders shows a five-year compound annual growth rate of -38.7% (FY2020 to FY2025).
- In prior years, Organon's Net Income towards Common Stockholders was $864 million in FY2024 (-15.5%), $1.02 billion in FY2023 (+11.6%), $917 million in FY2022 (-32.1%) and $1.35 billion in FY2021 (-37.5%).
- The Q3 2026 figure stands as the highest quarterly Net Income towards Common Stockholders since Q3 2024.
- On a year-over-year basis, Net Income towards Common Stockholders increased in two of the last seven quarters, with an average decline of 24.7%.
- The strongest year-over-year quarter for Net Income towards Common Stockholders in the past five years was Q3 2024, with growth of 519.0%; the weakest was Q4 2024, with a decline of 80.0%.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was $108 million (Q2 2026), $146 million (Q1 2026) and -$205 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Organon | 3.65 Bn | -629.18 Mn | 869.00 Mn | 164.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 164.00 Mn |
| Jun 30, 2026 | 108.00 Mn |
| Mar 31, 2026 | 146.00 Mn |
| Dec 31, 2025 | -205.00 Mn |
| Sep 30, 2025 | 160.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 109.00 Mn |
| Sep 30, 2024 | 359.00 Mn |
| Jun 30, 2024 | 195.00 Mn |
| Mar 31, 2024 | 201.00 Mn |
| Dec 31, 2023 | 546.00 Mn |
| Sep 30, 2023 | 58.00 Mn |
| Jun 30, 2023 | 242.00 Mn |
| Mar 31, 2023 | 177.00 Mn |
| Dec 31, 2022 | 108.00 Mn |
| Sep 30, 2022 | 227.00 Mn |
| Jun 30, 2022 | 234.00 Mn |
| Mar 31, 2022 | 348.00 Mn |
| Dec 31, 2021 | 202.00 Mn |
API Access
Organon Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=OGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "OGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=OGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();